CNO Financial Q3 operating EPS rises 47%, outlook raised

Overview

• US life and health insurer's Q3 operating EPS rose 47% year-over-year

• Company raised full-year operating EPS guidance, midpoint up 9% from prior

• CNO repurchased $60 mln in shares and closed $270 mln reinsurance transaction

Outlook

• CNO raises 2026 operating EPS guidance, midpoint up 9% from prior guidance

Result Drivers

• ACTUARIAL REVIEW - Co said significant items from its annual actuarial review had a $44.9 mln net favorable impact on net income and net operating income

• NEW PREMIUMS - Co said total new annualized premiums increased for the 17th consecutive qtr

• AGENT COUNT GROWTH - Co said Consumer and Worksite segments delivered their 15th and 17th consecutive qtrs of producing agent count growth

Company press release:

Key Details

Analyst Coverage

• The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy", 6 "hold" and no "sell" or "strong sell"

• The average consensus recommendation for the life & health insurance peer group is "buy."

• Wall Street's median 12-month price target for CNO Financial Group, Inc. is $56.00, about 3% above its October 28 closing price of $54.38

• The stock recently traded at 11 times the next 12-month earnings vs. a P/E of 11 three months ago

Reuters Recommended Reads

• Oct 28 - Kemper swings to preliminary Q3 profit as auto underwriting improves

• Oct 28 - Employers Holdings Q3 net premiums earned falls

• Oct 28 - Hanover Insurance Q3 premiums written rise 3%

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)